Achilles Heel In Cancer Cells Identified By Scientists

Achilles heel in a protein that shields tumour cells from cell death have been identified by scientists.

They believe that this weakness can be exploited to target and kill the very tumour cells that the protein usually protects.

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.

Akt is a signalling protein, called a kinase, that is hyperactive in the majority of human cancers.

"Akt is perhaps the most frequently activated oncoprotein (cancer-promoting protein) in human cancer," said Nissim Hay, professor of biochemistry and molecular genetics at the UIC College of Medicine.

"One of Akt's major functions in tumour cells is promoting cell survival.

Achilles Heel of HIV Uncovered, Says Indian-Origin Scientist
An Indian-origin researcher studying Human Immunodeficiency Virus (HIV) at The University of Texas Medical School at Houston claims that his team has uncovered the Achilles heel in

"Tumor cells with hyperactive Akt are not only resistant to the external stresses that can induce cell death but also to chemotherapy," Hay added.

During the study, the researchers were able to exploit Akt hyperactivity against the tumour cell.

Herpes Virus' Achilles Heel Found
A virologist at Duke University in Durham, North Carolina, says that it is possible to bring herpes simplex virus-1 (HSV-1) out of its hiding place inside the body, which can help

"We found that cells with hyperactive Akt have increased intracellular levels of reactive oxygen species (ROS) and at the same time impaired ability to scavenge ROS," Hay said.

"These ROS are highly reactive byproducts of metabolism that can damage the cell. Cells usually respond to high levels of ROS by undergoing cell suicide, or apoptosis.

Scientists Identify Achilles Heel of Common Childhood Tumor
Scientists have discovered how the common childhood tumour, infantile hemangioma, grows rapidly.

"And, to our surprise, we found that although Akt can protect cancer cells from many of the external signals that would ordinarily induce cell death, including many chemotherapy drugs, it cannot protect from ROS inducers," said Hay.

The researchers found that when the cancer cells were treated with chemicals that raised ROS levels, the cells died.

The new study "provides a proof of the principle that Akt's Achilles heel - a consequence of its role in metabolism - can be exploited in at least these two ways to selectively target and kill cancer cells," Hay said.

The new study is published in journal Cancer Cell.

Source-ANI
SK